Preclinical Medication Development: New Targets and New Drugs

Simple item page
dc.contributor.authorKasten, Chelsea R.
dc.contributor.authorBoehm, Stephen L., II
dc.contributor.departmentPsychology, School of Scienceen_US
dc.date.accessioned2018-05-07T14:22:34Z
dc.date.available2018-05-07T14:22:34Z
dc.date.issued2016-07
dc.eprint.versionAuthor's manuscripten_US
dc.identifier.citationKasten, C. R., & Boehm, S. L. (2016). Preclinical Medication Development: New Targets and New Drugs. Alcoholism, Clinical and Experimental Research, 40(7), 1418–1424. http://doi.org/10.1111/acer.13105en_US
dc.identifier.urihttps://hdl.handle.net/1805/16077
dc.language.isoen_USen_US
dc.publisherWileyen_US
dc.relation.isversionof10.1111/acer.13105en_US
dc.relation.journalAlcoholism, Clinical and Experimental Researchen_US
dc.rightsPublisher Policyen_US
dc.sourcePMCen_US
dc.subjectNeuropeptidesen_US
dc.subjectInflammationen_US
dc.subjectNeuroimmunologyen_US
dc.subjectAlcoholism -- Complicationsen_US
dc.titlePreclinical Medication Development: New Targets and New Drugsen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
nihms781479.pdf
Size:
110.13 KB
Format:
Adobe Portable Document Format
Description:
Main article
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.99 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Open Access Policy Articles
Department of Psychology Works